Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul F Robbins

Showing results (31-40 of 125) with videos related to

Pageof 13
Sort By:
Cancer Gene Therapy|October 19, 2002
MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cellsJ Mark Sloan, Michael H Kershaw, Christopher E Touloukian, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Irradiation enhances human T-cell function by upregulating CD70 expression on antigen-presenting cells in vitroJianping Huang, Qiong J Wang, Shicheng Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapySimon Turcotte, Alena Gros, Eric Tran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapyJianping Huang, Keith W Kerstann, Mojgan Ahmadzadeh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2020
Impact of Cysteine Residues on MHC Binding Predictions and Recognition by Tumor-Reactive T CellsAbraham Sachs, Eugene Moore, Zeynep Kosaloglu-Yalcin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2002
Identification of BING-4 cancer antigen translated from an alternative open reading frame of a gene in the extended MHC class II region using lymphocytes from a patient with a durable complete regression following immunotherapySteven A Rosenberg, Panida Tong-On, Yong Li, et al.
Cancer Research|July 5, 2002
Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine designGang Zeng, Yong Li, Mona El-Gamil, et al.
Journal for Immunotherapy of Cancer|July 29, 2021
Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencingYong-Chen Lu, Zhili Zheng, Frank J Lowery, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regressionJianping Huang, Hung T Khong, Mark E Dudley, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Structural characterization and AlphaFold modeling of human T cell receptor recognition of NRAS cancer neoantigensDaichao Wu, Rui Yin, Guodong Chen, et al.
Pageof 13

Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
Cancer Gene Therapy|October 19, 2002
MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cellsJ Mark Sloan, Michael H Kershaw, Christopher E Touloukian, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Irradiation enhances human T-cell function by upregulating CD70 expression on antigen-presenting cells in vitroJianping Huang, Qiong J Wang, Shicheng Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapySimon Turcotte, Alena Gros, Eric Tran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapyJianping Huang, Keith W Kerstann, Mojgan Ahmadzadeh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2020
Impact of Cysteine Residues on MHC Binding Predictions and Recognition by Tumor-Reactive T CellsAbraham Sachs, Eugene Moore, Zeynep Kosaloglu-Yalcin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2002
Identification of BING-4 cancer antigen translated from an alternative open reading frame of a gene in the extended MHC class II region using lymphocytes from a patient with a durable complete regression following immunotherapySteven A Rosenberg, Panida Tong-On, Yong Li, et al.
Cancer Research|July 5, 2002
Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine designGang Zeng, Yong Li, Mona El-Gamil, et al.
Journal for Immunotherapy of Cancer|July 29, 2021
Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencingYong-Chen Lu, Zhili Zheng, Frank J Lowery, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
Survival, persistence, and progressive differentiation of adoptively transferred tumor-reactive T cells associated with tumor regressionJianping Huang, Hung T Khong, Mark E Dudley, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Structural characterization and AlphaFold modeling of human T cell receptor recognition of NRAS cancer neoantigensDaichao Wu, Rui Yin, Guodong Chen, et al.
Pageof 13